Cost Effective Air Filtration for Kids’ Asthma in NYC Housing
Official title: Cost Effective Air Filtration Intervention and Particulate Matter Monitoring in Low-Income Housing to Reduce Asthma Morbidity
Run by Columbia University · NCT07116460 · Data updated 2026-11-12
Aiming to see if a cost-effective HEPA air cleaner used in homes of children with asthma in NYC can lower indoor pollution and improve asthma symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years to 18 Years |
| Sex | All |
| Enrollment | 55 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | January 30, 2026 |
| Main results expected | April 2028 |
| Study ends | April 2028 |
| Registry record updated | June 2, 2026 |
| Trial ID | NCT07116460 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 7-18 with recent asthma symptoms living in lower-income housing in NYC (Northern Manhattan and the South Bronx).
✕Probably not a fit
Participants who cannot complete spirometry or FeNO testing, or who plan to move within a year, may not benefit due to incomplete data collection.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests whether placing a single high-efficiency air cleaner in homes reduces indoor particulate matter and asthma morbidity among children with asthma in East Harlem and other low-income NYC neighborhoods. Over one year, researchers will monitor indoor air quality, ensure device use, and perform two lung-health tests, including exhaled nitric oxide and spirometry, along with asthma symptom questionnaires. The study builds on prior HUD-funded work and community partnerships to offer a simple, scalable home-based intervention without building changes. If successful, the approach could provide a affordable method to reduce asthma burden in urban, low-income populations.
Why it matters
Potential benefit: If successful, children may experience fewer asthma symptoms and better lung health with a low-cost, easy-to-implement home intervention.
How similar studies have gone: Previous home air cleaner studies in similar settings suggested reductions in indoor pollutants and asthma symptoms, supporting this approach's potential.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 7-18 years * Asthma symptoms in the past 4 weeks * Resident in lower-income housing in NYC Northern Manhattan and South Bronx Exclusion Criteria: * Inability to successfully perform spirometry maneuver or FeNO test * Family planning to move in the next year
Where it's running
-
Columbia University Irving Medical Center
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Matthew S Perzanowski, PhD — Columbia University
- Study coordinator: Matthew S Perzanowski, PhD
- Email: mp2217@cumc.columbia.edu
- Phone: (212) 305-3465
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Post-Exacerbation Asthma Telecare
This trial tests whether a structured remote pulmonology follow-up after an asthma flare‑up can reduce repeat exacerbations compared with usual care.
-
Astaxanthin to help manage asthma in polluted areas
This trial will test whether taking astaxanthin supplements can reduce airway inflammation and improve lung function and asthma control in adults with mild-to-moderate asthma who are exposed to air pollution.
-
Immune status and disease control in airway inflammatory diseases
This project will test whether specific blood immune cell patterns relate to disease control in adults with asthma, COPD, bronchiectasis, or obstructive sleep apnea by comparing them with healthy volunteers.
-
Boosting referrals to asthma specialists after an ER visit
This study tests whether arranging a telehealth follow-up with an asthma specialist from the ER helps adults with asthma see a specialist within 3 months more often than usual referrals.
-
Remote monitoring to predict asthma attacks in children and young people
This project will test whether combining routine health records with home monitoring data can predict and reduce asthma attacks in children and young people aged 5-17.
-
Nebulized ketamine added to standard care for moderate to severe asthma attacks
In adults with moderate to severe asthma attacks, this study tests whether inhaled ketamine given with standard treatment helps breathing better than standard treatment alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.